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The human immunodeficiency virus type 1 genomic RNA primer-binding site (PBS) sequence comprises 18
nucleotides which are complementary to those at the 3' end of the replication initiation primer tRNAALYS. To
investigate the role of the PBS in viral replication, we either deleted the original wild-type PBS (complementary
to tRNA3YS) or replaced it with DNA sequences complementary to either tRNAlys or tRNAPhe. Transfection of
COS cells with such molecular constructs yielded similar levels of viral progeny that were indistinguishable
with regard to viral proteins and tRNA content. Virus particles derived from PBS-deleted molecular clones
were noninfectious for MT-4, Jurkat, and CEM-T4 cells. However, infectious viruses were derived from
constructs in which the PBS had been altered to sequences complementary to either tRNA'LYs or tRNAPhe,
although mutated forms showed significant lags in replication efficiency in comparison with wild types.
Molecular analysis of reverse-transcribed DNA in cells infected by the mutated viruses indicated that both
tRNA1LY and tRNAPhe could function as primers for reverse transcription during the early stages of infection.
Sequencing of full-length proviral DNA, obtained 6 days after infection, revealed the mutated PBS, indicating
that a complete cycle of reverse transcription had occurred. During subsequent rounds of infection, reversion
of the mutated PBS to wild-type sequences was observed, accompanied by increased production of viral gene
products. Reversion to wild-type PBS sequences was confirmed both by specific PCR analysis, using distinct
primer pairs, and by direct sequencing of amplified segments. We also performed endogenous in vitro reverse
transcription experiments in which synthesis of minus-strand strong-stop viral DNA was primed from a
synthetic RNA template containing a PBS complementary to various tRNA isoacceptors. These results showed
that tRNA3yS was a much more efficient primer of such reactions than either tRNAlLY or tRNAPh.
An early, critical step in the human immunodeficiency virus
type (HIV-1) life cycle is reverse transcription of viral RNA
into proviral DNA, which can then be integrated into the
infected host cell genome. This process is carried out by the
multifunctional viral enzyme reverse transcriptase (RT) and
requires a primer annealed to a single-stranded template to
initiate DNA synthesis (9, 14, 18, 45, 47, 51). All retroviruses
use a cell-derived specific tRNA as primer, which is packaged
into mature virions (10, 11, 17, 22, 25, 34). Eighteen nucleo-
tides (nt) at the 3' end of tRNALYS are complementary to an
18-nt sequence of HIV-1 genomic RNA, termed the primer-
binding site (PBS). The PBS is found approximately 180 nt
from the 5' end of the viral genome (39). Preferential packag-
ing of tRNALYS and its tight association with viral RNA in the
virion suggests that it may function as a primer of reverse
transcription from the PBS. In addition, HIV-1 RT has been
shown to bind specifically to tRNA3YS through interactions
with the anticodon loop, TPC loop, and D loop of tRNALYS (1,
2, 4, 27). However, the question of specific binding between
HIV-1 RT and complexes of tRNA3YS annealed to a PBS
template has not been studied.
The viral genomic PBS is believed both to provide a site for
binding of primer tRNA, thereby allowing initiation of reverse
transcription, and to facilitate the second template switch (36,
46, 48, 50). Neither of these functions is well understood. In
addition, the PBS may play a role in the specific selection and
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packaging of primer tRNA'YS. Primer tRNA'YS may also play
a dual role in HIV reverse transcription, by initiating RNA-
dependent DNA polymerization from the PBS and by acting as
the PBS template during synthesis of plus-strand DNA (9, 13).
To study these multiple functions, the wild-type PBS se-
quence (complementary to the 3' end of tRNA3YS) in an
infectious molecular clone of HIV-1 was either deleted or
replaced with sequences complementary to either tRNAY2' or
tRNAPhe. The rationale for choosing these particular tRNA
species was that (i) tRNAY2' is utilized as primer for reverse
transcription in other retroviruses, e.g., Mason-Pfizer monkey
virus (27, 50), whereas tRNAPhe has never been identified as a
reverse transcription initiation primer, and (ii) while tRNALys
is packaged into wild-type HIV-1 in amounts even greater than
those of the wild-type primer tRNALYS, tRNAPhe is present at
much lower levels, i.e., around 1% (22, 49).
We now describe the effects of alterations in the HIV-1 PBS
on viral replication and on virion tRNA content. We found
that the quantities and patterns of tRNA species incorporated
into virions were unaffected either by the absence of a PBS or
by the presence of altered PBS sequences, indicating that the
PBS does not play a significant role in the selection and
incorporation of primer tRNA during HIV-1 assembly. How-
ever, deletion of the 18-nt wild-type PBS completely abolished
viral infectivity, whereas its replacement with sequences com-
plementary to either tRNALys or tRNAPhe impaired but did
not abort viral infectivity. Interestingly, the mutant PBS se-
quences reverted to wild type during infection. The ability of
these various viruses to replicate was closely related to the
status of the PBS. During early stages of infection, the two PBS
mutants, in conjunction with tRNA1Ls and tRNAPhe, appar-
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ently functioned as primers for reverse transcription, although
less efficiently than wild-type primer tRNALYS.
(This research was largely performed by X.L., under the
joint supervision of M.A.W. and M.A.P., in partial fulfillment
of the requirements for the Ph.D. degree, Faculty of Graduate
Studies and Research, McGill University, Montreal, Quebec,
Canada.)
MATERIALS AND METHODS
Cells, viruses, and plasmids. The following reagents were
obtained through the NIH AIDS Research and Reference
Reagent Program, Division of AIDS, National Institute of
Allergy and Infectious Diseases: the pBH10 noninfectious
plasmid used as a nick translation probe in Northern (RNA)
blots (donated by R. C. Gallo); the HXB2D infectious molec-
ular clone of HIV-IIIB, containing the full-length HIV-1
proviral genome (provided by G. Shaw and B. Hahn); and the
CD4+ MT-4 cell line (contributed by D. Richman). Other
cells, including the CD4- RD (rhabdosarcoma), simian-de-
rived COS-7, CD4+ CEM, and Jurkat cell lines, were pur-
chased from the American Type Culture Collection, Rockville,
Md. Each of the CD4+ cell lines was susceptible to acute
cytopathic HIV-1 infection, while the CD4- lines were not.
Cells were routinely maintained in RPMI 1640 medium
(Gibco-BRL Laboratories, Toronto, Ontario, Canada) supple-
mented with 10% fetal calf serum, 100 U of penicillin per ml,
and 100 ,ug of streptomycin per ml. pSCV21, a eukaryotic
expression vector containing the full-length HIV-1 genome
with a simian virus 40 origin of replication (15), was a gift of E.
Cohen, Universite de Montreal, Montreal, Quebec, Canada.
pSVK3 and pSP72 were purchased from Pharmacia Inc. (Mon-
treal, Quebec, Canada) and Promega (Nepean, Ontario, Can-
ada), respectively. Recombinant HIV-1 RT (p66/p5i het-
erodimer) was kindly provided by Casey Morrow, University of
Alabama at Birmingham. Restriction enzymes and other mod-
ified enzymes were obtained from Pharmacia.
Construction of HIV-1 proviral plasmids with altered PBS
sequences. The PBSs of HIV-1 molecular clones were altered
by using a combination of linker replacement and site-directed
mutagenesis (44). Briefly, HXB2D was cut with SmaI andApaI
to generate a 3.7-kb fragment comprising the 5' region of the
HIV-1 proviral genome and cellular flanking sequences. This
fragment was subcloned into Smal-Apal-digested pSVK3 to
give pSVPBS, which was used for the subsequent construction
of PBS mutants. pSVPBS was digested with NarI and then
treated with a mung bean nuclease to generate blunt ends. The
plasmid was then cut with BssHII to remove 70 HIV nucleo-
tides including the PBS and downstream sequences. We then
ligated various 70-nt oligonucleotide sequences into the gap
created by the NarI and BssHII digestions described above.
These inserts contained PBS-like sequences complementary to
tRNA'12' and tRNAPhe to yield pSVPBS-Lysl,2 and pSVPBS-
Phe, respectively. Standard site-directed mutagenesis was used
to delete the entire 18-nt region ofpSVPBS to yield pSVPBS(-).
The sequences of our various 18-nt PBS constructs are as
follows: 5'-TGG CGC CCG AAC AGG GAC-3' (pPBS-WT),
5'-TGG CGC CCA ACG TGG GGC-3' (pPBS-Lysl,2), and
5'-TGG TGC CGA AAC CCG GGA-3' (pPBS-Phe).
The SmaI-ApaI fragments from pSVPBS, pSVPBS(-),
pSVPBS-Lysl2, and pSVPBS-Phe were then cloned into the
appropriately digested pSCV21 molecular clone of HIV-1 to
yield expression plasmids containing full-length HIV-1 proviral
DNA with the wild-type PBS (pPBS-WT) and mutated PBSs
[pPBS(-), pPBS-Lysl,2 and pPBS-Phe]. All constructs were
sequenced to verify that the correct modifications in PBS
sequence had been achieved.
Each of the plasmids described above, containing altered
PBS sequences, was cut with BglII and PstI to generate a
fragment of 947 bp (473 to 1420), comprising the PBS/U5/R
region of HIV-1 proviral sequences (3). Such fragments were
then ligated into the RNA expression vector pSP72, at the gap
created by PstI and BglII, to generate various HIV-1 RNA
expression plasmids containing altered PBS sequences.
Synthesis of minus-strand strong-stop DNA in an endoge-
nous in vitro RT assay. The HIV-1 RNA expression vectors
described above were linearized byAccI (nt 956) (39) and used
in the Promega Riboprobe Gemini Core System to generate
runoff transcripts of 483 ribonucleotides with alterations in the
PBS region. In vitro RT assays were carried out in a volume of
20 pLl containing 10 mM dithiothreitol, 50 mM Tris-HCl (pH
7.8), 100 mM KCl, 10 mM MgCl2, and 0.2 mM each of the four
deoxynucleoside triphosphates as described previously (3).
tRNAlL'2s, tRNALYS, and tRNALYSPhe were purified from human
placenta (22, 42). Reaction mixtures were supplemented with
0.3 ,ug of recombinant HIV-1 RT together with 200 U of
RNasin (RNase inhibitor; Gibco-BRL, Toronto, Ontario, Can-
ada) and incubated at 37°C for up to 15 min. Reactions were
terminated at various times by addition of EDTA to 100 mM.
The terminated mixtures were extracted with phenol-chloro-
form and chloroform and passed through a Sephadex G-25
(Pharmacia) column to remove unincorporated free radioac-
tive nucleotides. The products of these reactions were boiled
for 4 min in formamide gel loading buffer (44) and chilled on
ice for 5 min before being loaded onto a 5% denaturing
polyacrylamide gel. The full-length minus-strand strong-stop
DNA synthesized in these reactions is 249 nt long.
Infection of target cells. COS-7 cells were transfected with
the pPBS constructs by electroporation. After 60 h of incuba-
tion, cell-free virus stocks were prepared by centrifugation of
culture supernatants at 3,000 rpm at 4°C for 30 min in a
Beckman bench-top centrifuge and filtration through a 0.2-
,um-pore-size sterile membrane (Becton Dickinson, Oxnard,
Calif.). To remove possible contaminating plasmid DNA,
which could interfere with our PCR assays (see below), the
virus stock was treated at 37°C for 30 min with excess DNase
I at a final concentration of 100 U/ml in the presence of 10mM
MgCl2 (35). The virus-containing clarified culture fluids were
stored at -70°C until use.
Infectiousness of virus particles produced by transfection of
COS-7 cells was determined by using MT-4, Jurkat, or CEM
cells as targets. Briefly, 5 x 105 cells were harvested during
exponential growth, washed once by centrifugation, and incu-
bated in medium containing 5 ng of viral p24, supplemented
with 10 ,ug of Polybrene per ml, at 37°C for 3 h with occasional
gentle shaking. Unbound viruses were removed by four sepa-
rate centrifugation washings in serum-free medium, and the
cells were resuspended in fresh medium. To ensure complete
removal of contaminating plasmid DNA, medium from the
fourth wash was checked by PCR using primer pairs specific
for the HIV-1 RT gene (16). Cell culture medium was changed
at 3- to 4-day intervals. Samples of cells and cell-free culture
supernatants were collected at regular intervals and assayed
for virus content by HIV-1 p24 antigen expression and RT
assay (5). Samples from MT-4 cells infected by heat-inacti-
vated pPBS-WT (60°C, 30 min) served as negative controls
(52).
PCR analysis and DNA sequencing. Infected cells (5 x 105)
were suspended in 0.5 ml ofTE buffer (50mM Tris-HCl, 1 mM
EDTA [pH 8.0]) containing 0.5% sodium dodecyl sulfate
(SDS) and 0.5 mg of pronase per ml and incubated at 37°C for
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FIG. 1. Primer location and strategy for detection of viral DNA by PCR. (A) Sequences of primers used in PCR. (B) PCR strategy. Primer pairs
were chosen to distinguish the three types of PBS studied (PS/Lysl,2, PS/Phe, and PS/Lys3) or to detect full-length proviral DNA (PS/PA). The
latter primer pair was used to amplify a region flanking the PBS. Amplified fragments were subsequently analyzed by using the PS primer to
sequence minus-strand DNA and the PA primer to sequence plus-strand DNA, using a dsDNA cycling sequencing system (Gibco-BRL).
5 to 8 h with gentle shaking. The samples were then extracted
with TE-saturated phenol and chloroform-isoamyl alcohol.
Both total DNA and high-molecular-weight (HMW) DNA
were isolated by standard methods (44); the former was used
for PBS sequence analysis, while the latter served for determi-
nations of integrated HIV-1 proviral DNA. Samples were then
analyzed by PCR.
Selected primer pairs were used in PCR analysis of the PBS
sequences of various viral DNA species (unintegrated inter-
mediates or integrated forms). The sequences, locations, and
orientations of the primer pairs, designed to detect DNA
species with contiguous R and PBS sequences, as well as a
description of the products formed, are illustrated schemati-
cally in Fig. 1. Primer pair PS/PA amplifies full-length proviral
DNA and therefore detects the completion of reverse tran-
scription (13, 52). Three sets of primer pairs, PS/Lysl,2,
PS/Phe, and PS/Lys3, were used to distinguish the three types
of PBS studied. To distinguish PBS forms, highly stringent
PCRs were performed with 50 ,ug of sample DNA, 50 mM
Tris-Cl (pH 8.0), 50 mM KCl, 2.5 mM MgCl2, 5 pmol of
32P-end-labeled sense primer, and 20 pmol of unlabeled anti-
sense primer. Reactions were run for 25 cycles of 94°C (2 min)
and 65°C (2 min). Other PCRs were performed with 50 pM
of unlabeled primers (sense and antisense) for 30 cycles of
94°C (2 min), 60°C (2 min), and 72°C (2 min). Reactions
were standardized by simultaneous amplification of ,-globin
DNA (52) (primer pair, 5'-ACACAACTGTGTTCACTAG
C-3' [sense] and 5'-CAACTTCATCCACGTTCACC-3' [anti-
sense]). For direct sequencing of the R/U5/PBS region (LTR/
Gag), PS/PA amplified fragments (367 bp) were resolved by
electrophoresis, purified by electroelution, and sequenced by
using a PCR-based double-stranded DNA (dsDNA) cycling
sequencing system (Gibco-BRL).
Identification of tRNA species in virus particles. A dot blot
assay using DNA oligonucleotides complementary to the 3'
end of tRNA3YS (probe sequence, 5'-TGGCGCCCGAACAG
GGAC-3'), tRNALys (probe sequence, 5'-TGGCGCCCAAC
GTGGGGC), or tRNAPhe (probe sequence, 5'-TGGTGCCG
AAACCCGGGA-3') was used to identify specific tRNA spe-
cies. Positive controls, including tRNA1,2, tRNA'he, andtRNALYS, were purified from human placenta (22, 42). The
specificities of these probes and hybridization conditions have
been described elsewhere (22, 30). Total RNA was purified
from viruses as described previously (6), and the amount of
viral RNA was normalized according to copy numbers of
HIV-1 genomic RNA. Total RNA corresponding to 4 x 108
copies of viral genomic RNA was used in each analysis. RNA
samples were blotted onto Hybond N filters (Amersham) and
hybridized separately with each of the three probes. Following
high-stringency washing (22, 30), the filters were air dried and
exposed to X-ray film at -70°C.
RESULTS
Alteration of PBS sequences does not affect expression of
the proviral genome. The infectious HIV-1 clone pPBS-WT,
which possesses a wild-type PBS complementary to tRNALYS,
was altered (i) by deleting the 18-nt PBS to give pPBS(-) or
(ii) by replacing the wild-tpe PBS with sequences complemen-
tary to tRNA1LY or tRNA he to give pPBS-Lysl,2 or pPBS-Phe,
respectively. These mutant constructs were transfected into
COS-7 cells, and virus particles were harvested after 60 h.
Northern blotting and Western blotting (immunoblotting)
were performed to study expression of the proviral genome.
All of our wild-type (pPBS-WT) and mutated molecular clones
produced the usual three major HIV RNA transcripts; no
differences were noted among the various clones, nor were
differences found in the patterns of proteins in the viral
J. VIROL.
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FIG. 2. (A) Infection of MT-4 cells with viruses harvested from COS-7 transfections. Viral inocula were equalized on the basis of either p24
content (5 ng) or RT activity (800,000 cpm) to infect 5 x 105 cells. Cultures were regularly monitored for HIV-1 production by RT assay following
infection by PBS(-) (O), PBS-Lysl,2 (0), PBS-Phe (A), or PBS-WT (0). A, infection by pPBS-WT (heat-inactivated virus). No fresh cells were
added during the 24-day study period, in order to observe viral particle accumulation in culture supernatants. (B) Second round of infection of
MT-4 cells by viruses obtained from initially infected cultures (9 days following infection by pPBS-WT and 18 days following infection by
pPBS-Lysl,2 or pPBS-Phe). For symbols, see above.
progeny produced after transfection with each of the con-
structs.
We also transfected the various PBS constructs into the
CD4- RD cell line, which permits only one round of viral
replication (32). No significant differences were observed with
regard to levels of RT activity in culture fluids after various
times following transfection with pPBS-WT, pPBS(-), pPBS-
Lysl,2, or pPBS-Phe (data not shown). The transient nature of
these infections is apparent by the peak in RT activity after 10
to 15 days. These results are not surprising, considering that
neither the PBS nor reverse transcription is involved in viral
replication following transfection with proviral DNA.
Effects of alterations in the PBS on viral infectivity. Viral
particles were harvested from COS-7 transfection cultures
after 60 h, normalized according to p24 content (approximately
5 ng), and used to infect a variety of HIV-susceptible cell lines,
including MT-4, Jurkat, and CEM. Culture supernatants were
regularly monitored both for HIV-1 p24 antigen expression
and RT activity over 4 weeks.
Infection of MT-4 cells with pPBS-WT resulted in the rapid
emergence of RT activity, syncytia, p24 Ag+ cells as measured
by indirect immunofluorescence assay, and other cytopathic
effects within 2 days. Virtually, all cells were p24 Ag+ after 1
week, at which time RT activity had peaked. RT activity
gradually declined with death of infected cells. In contrast, only
5 to 10% of cells transfected by pPBS-Lysl,2 or pPBS-Phe
were p24+ after this period, and RT activity in culture fluids
was low (Fig. 2A). Virus particles produced from COS cells
transfected with pPBS(-) were unable to infect MT-4 cells. No
cytopathic effect, p24 antigen, or RT was detected even after
30 days. We noted that virus production by cells infected with
the two PBS mutants reached normal levels by 15 to 18 days.
Similar virus production kinetics were noted when either
Jurkat or CEM cells were used as targets (data not shown),
suggesting that cell type differences were not responsible for
the observed results with mutated PBS-containing viruses.
The progeny of these MT-4 infections (9 days from
pPBS-WT infection and 18 days from pPBS-Lysl,2 and pPBS-
Phe infection) were then used in a second round of replication
in MT-4 cells. Figure 2B shows that high rates of replication,
equivalent to those obtained with wild-type viruses, were
observed when the progeny of pPBS-Lysl,2 or pPBS-Phe,
obtained at 18 days, were studied for the ability to infect MT-4
cells. In contrast, when the progeny of MT-4 infections,
obtained after 6 days, were compared for infectiousness in a
second-round infection, infection kinetics similar to those of
Fig. 2A were observed (data not shown). This result suggests
that wild-type PBS forms had preferentially emerged during
the 24-day period of study; this subject will be considered in
Discussion.
PCR analysis of the PBS sequence of proviral DNA in
infected cells. The specificity of our PCR assay was monitored
by mixing 0.1 ng of cloned HIV plasmid (wild type or mutated)
with 50 ,ug of MT-4 DNA from uninfected cells. The R/U5/
PBS region of each type of HIV genomic DNA was amplified
by using the three sets of primer pairs, PS/Lysl,2, PS/Phe, and
PS/Lys 3, described in Fig. 1. Each HIV clone could be
amplified only by its own specific primer pair, e.g., pPBS-Lysl,2
by PS/Lysl,2 and not PS/Lys3 or PS/Phe (Fig. 3A, lane 2). Also,
primer pair PS/Lysl,2 could not amplify any of the R/U5/PBS
region of PBS(-) (Fig. 3A, lane 1), pPBS-Phe (lane 3), or
pPBS-WT (lane 4).
The three sets of primer pairs were used to analyze PBS
sequences in DNA harvested from MT-4 cells at various times
after infection by the various viral clones. Total cellular DNA
was used to simultaneously detect PBS sequences in interme-
diate viral DNA species as well as in full-length integrated
proviral DNA. At all times, we detected only wild-type PBS
sequences in DNA extracted from MT-4 cells exposed to
pPBS-WT virions, starting 3 days after infection (Fig. 3B). At
24 days after infection, the intensity of this band had de-
creased, apparently as a result of virus-induced cytopathicity.
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TABLE 1. PBS sequences detected by direct dsDNA sequencing'
MT-4 cells PBS sequence
infected by: 6 days postinfection 24 days postinfection
pPBS-WT TGGCGCCCGAACAGGGAC TGGCGCCCGAACAGGGAC
pPBS-Lysl,2 TGGCGCCCAACGTGGGGC TGGCGCCCGAACAGGGAC
pPBS-Phe TGGTGCCGAAACCCGGGA TGGCGCCCGAACAGGGAC
a Primer pair PS/PA was used to amplify a region flanking the PBS. Amplified
fragments were subsequently analyzed by using a dsDNA cycling sequencing
system (Gibco-BRL).
B
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PS/Lysl,2
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D show results frc
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I-Globin served a
W * w In contrast, only mutated PBS forms were present in cells
infected with pPBS-Lysl,2 or pPBS-Phe at 6 days after infec-
1 2 3 4 5 6 7 8 9 10 l 1 12 tion (Fig. 3C and D). By 9 days after infection, the wild-typePBS had started to emerge, while mutated PBS forms had
3 days 6 days 9 days 12 days 1 5 days 24 days begun to disappear, concomitant with high levels of release of
infectious progeny by these cells (Fig. 2A). To rule out possible
PCR artifacts, we used primer pair PS/PA (Fig. 1) to amplify a
+ + + + + + 367-bp fragment flanking the PBS region in DNA isolated
+ + + + + + from MT-4 cells infected with each of the wild-type and
+ + + + + + mutated viral forms. Sequencing confirmed that the PBS which
+ ., * ,* was detected early (i.e., up to 6 days) in cells infected by
mutated viruses contained the original mutations. However, at
later times, only wild-type PBS sequences were found, while
mixtures were apparently present at intermediate time points,
as suggested by the presence of multiple bands at such times.
3 days 6 days 9 days 12 days 1 5 days 24 days A summary of DNA sequencing results with respect to the PBS
, mrI is shown in Table 1.
+ ++ ,+ +, + + Determination of minus-strand strong-stop DNA synthesis
+ + + + + + as measured by endogenous in vitro reverse transcription. To
+ + + + + + determine the efficiency of reverse transcription initiated by
different tRNA primers, we used an endogenous in vitro
* _, *. * * * reverse transcription assay (3) that employed synthetic RNA
templates containing mutated PBS sequences together with
1 2 3 4 5 6 7 8 9 10 11 12 13 14 1516 17 18 their respective tRNA primers. When synthetic pPBS-WT
RNA template was primed with tRNALys, full-length minus-
3 days 6 days 9 days 12 days 15 days 24 days strand strong-stop DNA products were detectable within 1 mindays 6rdays 9days 12 days i 5 days 24 days of addition of RT to the reaction mixture (Fig. 4, lane 1).
However, when reactions involving synthetic pPBS-Lysl,2 and
+ ++ + + + pPBS-Phe RNA templates were primed with tRNAL2s and
+ + + + + + tRNAPhe, respectively, full-length minus-strand strong-stop
+ + + + +
_
+ DNA (249 nt) was not detectable until after 15 min (Fig. 4,
K__ :*' * * lanes 7 and 11). None of the tRNAs were able to prime
minus-strand strong-stop DNA synthesis from a synthetic
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 161718 pPBS(-) RNA template (Fig. 4, lanes 4, 8, and 12), indicating
the specificity of the 249-nt products generated. The faster-
pecificity of PCR for differentiation of PBS se- moving bands (molecular size, <249 nt) in Fig. 4 are probably
d as a sense primer, while Lysl,2, Phe, and Lys3 were due to pausing of DNA synthesis by RT during DNA synthesis
,. Primer pairs PS/Lysl,2, PS/Phe, and PS/Lys3 were (19, 24).
PBS complementary to tRNALy~2, tRNAPhe, and Alteration of HIV-1 PBS does not abolish the reverse
ively. For this purpose, linearized PBS constructs transcription cycle. The retrovirus PBS is thought to facilitate
Lysl,2, pPBS-Phe, and pPBS-WT] were mixed with the second template switch which occurs dunn reverse tran-
;ed cellular DNA and subjected to PCR in separate gcription.tete fllt h occurstd rovi ran-
e above-described primer pairs. The sensitivities of scription To detect full-length integrated proviral DNA by
pairs were similar, and specificity was present over a PCR, we studied HMW DNA of infected MT-4 cells by using
concentrations. The intensities of reaction products primer pair PS/PA (Fig. 1), which amplifies the last region of
ng plasmid and an exposure time of 2 h at -70°C are reverse-transcribed proviral DNA (13). Figure 5 shows that
D) PCR analysis of PBS in reverse-transcribed DNA. full-length proviral DNA was detected throughout the course
nfected cells at five time points was analyzed by PCR of infection by wild-type and mutated viruses. This was true
ts of primer pairs described above (A). Panels B to even at early time points of infections (6 days) involving
im MT-4 cells infected by PBS-WT, PBS-Lysl,2, and mutated viruses, when only mutated PBS forms were present
tively; 50 ,ug of DNA was used in each reaction. (Fig. 5).
is an intemnal control (not shown). The identity of the PBS sequences of integrated proviral
DNA was next confirmed by sequencing 367-bp fragments
amplified by primer pair PS/PA (Fig. 1). The PBS sequences in
PS/Lys 1 ,2
PS/Phe
PS/Lys3
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FIG. 5. Detection of full-length integrated proviral DNA from
infected cells. HMW DNA was analyzed by PCR using primer pair
PS/PA, which detects full-length proviral DNA (13, 52). Fresh cells
_ 118 were added into parallel infection cultures to facilitate isolation of
relatively intact HMW DNA (on day 12 after pPBS-WT infection and
on day 18 after infections by pPBS-Lysl,2 and pPBS-Phe). Amplified
products were electrophoresed on 1.5% agarose gels and detected by
staining the gels with ethidium bromide. Lane -, HMW DNA from
MT-4 cells infected by heat-inactivated pPBS-WT; lane m, 100-bp
DNA ladder (Gibco-BRL).
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FIG. 4. Detection of minus-strand strong-stop DNA synthesis in an
in vitro RT assay. Synthetic RNA templates containing altered PBS
sequences were primed with tRNAL", tRNAPhe, and tRNAVs, respec-
tively, in minus-strand strong-stop DNA synthesis reactions. Lanes: 1
to 3, pPBS-WT RNA template primed by tRNA3LYs; 4, pPBS(-) RNA
template primed by tRNA3L3"; 5 to 7, pPBS-Lysl,2 RNA template
primed by tRNAjYs; 8, pPBS(-) RNA template primed by tRNA,'r2; 9
to 11, pPBS-Phe RNA template primed by tRNAPhe; 12, pPBS(-)
RNA template primed by tRNAPhe. The full-length minus-strand
strong-stop DNA [(-) ssDNA] product is 249 nt long. Bands with
molecular sizes smaller than 249 nt are incomplete minus-strand DNA
products, possibly due to pausing by RT during DNA synthesis (19,
24).
HMW DNA after 6 days were all of the mutated variety in cells
infected with the mutant virus PBS-Lysl,2 or PBS-Phe. How-
ever, only wild-type PBS sequences were detected after 24
days. The PBS sequences at intermediate times (e.g., day 12 in
PBS-Lysl,2-infected cells and day 9 in PBS-Phe-infected cells)
were a mixture of both mutants and wild types.
Identification of the tRNA species in mutant viruses. Three
different oligonucleotide probes, complementary to the 3' ends
of tRNAl, tRNAPhC, and tRNA, , respectively, were used to
detect these tRNA species in purified virus particles, using
hybridization conditions and purified human placental tRNA
isoacceptor species, as described previously (22, 30). These
analyses were carried out by dot blot hybridization; all patterns
of reactivity were specific, and no cross-hybridization was
observed among the probes used with any tRNA isoacceptor
species. For example, the tRNAPhe-specific probe did not show
cross-hybridization to either tRNAIL2S or tRNA3L3" (Fig. 6A to
C), which share more than 60% homology at the 18-nt 3' end.
No significant differences in levels of tRNAl , tRNAPhe, or
wild-type primer tRNA3LYS were found in each of the three
mutant compared with wild-type viruses (Fig. 6A to C). Thus,
replacement of the wild-type PBS with sequences complemen-
tary to tRNAIL2S or tRNA e did not alter the pattern of tRNA
species incorporation into viral progeny (Fig. 6). Two-dimen-
sional polyacrylamide gel electrophoresis analysis of tRNA
species in these various virus particles did not reveal significant
differences among the wild type and pPBS(-), pPBS-Lysl,2,
and pPBS-Phe mutants (data not shown). Thus, the PBS does
not appear to be involved in the selective incorporation of
tRNA species into mature virions.
DISCUSSION
Reverse transcription of retroviral genomic RNA into pro-
viral DNA is an early and essential step in the HIV life cycle.
The role of the PBS in this process is to provide a complemen-
tary region for the binding of the specific tRNA isoacceptor
species, which serves as a primer for RNA-dependent DNA
polymerization, and to facilitate the second template switch,
allowing completion of full-length double-stranded proviral
DNA (12, 26, 28, 31, 33, 38, 43).
This study of PBS sequences was based on the utility of
tRNA as a primer of retroviral RT and the abundance of
tRNA species in HIV-1 virions. We were unable to detect
significant differences among tRNA isoacceptors in terms of
packaging into mature virions, consistent with results that
showed deletion of either long terminal repeat or PBS se-
quences did not disrupt tRNA patterns in viruses (22). Viral
proteins, including the Pr1606'""' precursor, probably play an
important role in the selection of tRNA isoacceptors (30).
Virus particles harvested from transfected COS-7 cells were
assessed for infectivity, using MT-4, CEM-T4, and Jurkat cells
as targets. Not surprisingly, virus produced from pPBS(-)
transfections were noninfectious, consistent with previous ob-
servations (40). A novel finding of this study is that virus
produced after transfection by the two PBS replacement
mutants, pPBS-Lysl,2 and pPBS-Phe, were infectious, al-
though less so than wild-type viruses. However, despite a delay
in production of viral p24 (CA [capsid]) and RT, the rate of
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FIG. 6. (A to C) Identification of tRNA species in viral particles by dot blotting using DNA oligonucleotides complementary to the 3' end of
tRNALys (A), tRNAPhe (B), or tRNALYS (C). The specificity and hybridization conditions of this assay have been described elsewhere (22, 30). RNA
samples were obtained from purified viruses produced by COS-7 cells after transfection with pPBS constructs. Dots 1 to 4 designate viral RNA
from COS-7 cells transfected by pPBS-WT, pPBS(-), PBS-Phe, and PBS-Lysl,2, respectively. Dots 5 to 7 designate purified human tRNALY,
tRNAPhC, and tRNALYS, respectively. (D) Comparison of tRNA isoacceptors packaged into viruses. Each experiment was repeated three times. The
relative intensity of each dot from the hybridizations in panels A to C was estimated by laser scanning in an LKB film laser scanner. Results are
expressed ± standard deviation. *, pPBS-Phe; O, pPBS-Lysl,2; El, pPBS(-); E, pPBS-WT.
virus replication by these mutants eventually reached wild-type
levels. Mutant viruses derived from early and late stages of
infection were used to reinfect MT4 cells; we found that the
early-stage-derived virus continued to lag in infection kinetics,
while late-stage virus behaved indistinguishably from the wild
type. As discussed below, this shift in phenotype corresponded
to a reversion to a wild-type PBS. Other workers have also
reported differential results with use of mutated PBS se-
quences in a different system involving only a single round of
viral replication (29).
During plus-strand DNA synthesis, tRNA serves as the
template for the generation of the PBS, thus enabling identi-
fication of the tRNA isoacceptor used as a primer. PCR
analysis at early time points of the PBS sequences found within
the HMW DNA of cells infected by PBS-Lysl,2 or pPBS-Phe
showed complementarity to tRNA1,2 and tRNAPhe, respec-
tively. In contrast, the PBS sequences of proviral DNA from
later stages of these infections were complementary to wild-
type primer tRNALYS, indicating that synthesis and apparent
selection of wild-type forms had occurred. Thus, both tRNAlLY
and tRNAPhe appear to serve as primers for reverse transcrip-
tion during early stages of infection. However, at late stages, it
is likely that tRNALYs alone can serve this role. Our data show
that the replication competence of HIV-1 clones is closely
related to the status of the PBS. Our use of synthetic RNA
templates and mutated PBS in cell-free RT assays showed that
tRNA1LY and tRNAPhe were inefficient primers of minus-
strand strong-stop DNA synthesis. This may explain the lag in
virus production kinetics when the two PBS mutants were
studied in a replication-competent system.
Despite the ability of tRNA1LY and tRNAPhO to serve as
primers, both mutated PBS forms eventually reverted to
wild-type complementary to tRNALYS. It is unlikely that this
development was due to contamination and amplification of
small quantities of wild-type forms, since our molecular provi-
ral clones had been repeatedly subcloned and purified and
were pure by sequencing. Also, specific PCR showed that only
mutant PBS forms were present in proviral DNA at early
stages of infection by mutated viruses. No reversion of the
PBS- mutant was noted, as might have been expected if the
reversions with PBS-Lysl,2 and PBS-Phe were due to contam-
ination.
Although the mechanisms responsible for the observed
reversion are uncertain, it is known that the HIV RT binds
preferentially to tRNALYS (4, 21, 37, 41) and that interaction
between retroviral U5 RNA and the TTC loop of the tRNATrP
may be required for efficient initiation of reverse transcription
(1, 2, 7, 8, 27). Recent studies have shown that a 4-nt sequence
in the anticodon loop of tRNALYS interacts with HIV-1
genomic RNA in a region upstream from the PBS (20). The
resulting loop-loop interaction between tRNA and RNA tem-
plate, combined with normal PBS-tRNA binding, might give
rise to significant alterations in secondary structure of the
primer-template complex relative to that occurring when only
the 18 nt of the viral PBS interact with tRNA (as in the case of
the pPBS-Lysl,2 and pPBS-Phe mutants). The stability of
additional tRNA-RNA template interactions might be depen-
dent on particular base modifications found only in tRNALYS.
Such interactions could play a role in formation of RT-tRNA-
RNA template transcription complexes, thereby affecting tran-
scription efficiency. Results of our endogenous, in vitro reverse
transcription reaction showed that initiation with tRNALYS andtRNAPiTe occurred less efficiently than with tRNA3Ys when
minus-strand strong-stop DNA synthesis was primed from an
RNA template containing a PBS complementary to the respec-
tive tRNA isoacceptors (Fig. 4).
tRNALYs has extensive 3'-end homology with both tRNALys
(71%) and tRNAPhe (62%) and was incorporated into our PBS
mutant viruses at levels similar to those found with wild types.
Homology among these tRNA species implies that tRNALYS
could conceivably anneal to a mutant PBS; such annealing
might be further stabilized by the tRNA-RNA template inter-
actions discussed above. Thus, tRNALYS might be able to prime
reverse transcription even from a mutant PBS. Since reverse
transcription with tRNALys is more efficient than that with
tRNALys or tRNAPhe, it is conceivable that mutant viruses
might preferentially use a wild-type primer, leading to the
reverse transcription from tRNA3YS of a wild-type PBS and a
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consequent increase in viral production. Other factors that
may affect reversion of the PBS to wild type include specific
interactions between the HIV-1 RT and tRNA3YS and the
preferential incorporation of tRNALYS isoacceptors into viri-
ons. Since the PBSs of both proviral plus-strand strong-stop
DNA and full-length plus-strand DNA reflect the identity of
the tRNA primer, the use of tRNALYS as a primer for viruses
containing a mutated PBS might eventually result in reversion
to a wild-type sequence. It is still unclear whether cellular
factors may be involved in reverse transcription (24, 52).
Further insight will be possible once the factors involved in the
selection, incorporation, and placement of primer tRNA onto
the HIV-1 PBS in vivo are better understood (23, 25, 30, 32).
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